THERIOSOL

Indicaton

antibiotic replacement with blend of natural molecules. No phenotype resistance

Therapeutic indications

Infectious disease

Type of product

Small molecule

Table

Phase

Phase I completed
Available in

France

You may also be interested in

Regkirona (regdanvimab)

Regdanvimab is indicated for the treatment of adults with coronavirus disease 2019 (COVID-19) who do not require supplemental oxygen and who are at increased risk of progressing to severe COVID-19

Marketed

Cadazolid

Crohn's disease

Phase II started

Zevtera / Mabelio (ceftobiprole)

Acute bacterial skin and skin structure infections (ABSSSI)

Phase III completed